Direct link to deposited data
Deposited data can be found here: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE42221 and http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE42056.
Experimental design, materials and methods

Patient samples
All primary human samples were obtained upon approval by Institutional Ethics Boards. Patients were recruited by the COALL multicenter clinical trial group (Germany) and enrolled in trials COALL 97 and 03.
For patient characteristics and clinical data refer to Table 1 . Mononucleated cells (MNC) from bone marrow or peripheral blood were processed by gradient centrifugation (Biocoll separation solution, Biochrom) and cryopreserved.
Gene expression array
For a comparative matched pair expression analysis, single primary leukemic cells and normal lymphoblasts were isolated from the same individual, using a MoFlow Cytomation instrument by CD34, CD10 and CD19 staining. Please note that primary ALL I4 had a blast fraction of greater than 95% and was included without single cell sort due to experimental circumstances. Total RNA was isolated from a minimum of 4 × 10 3 mononucleated cells. Quality and concentration of isolated RNA were determined using an Agilent RNA 6000 Nano kit on an Agilent Bioanalyzer. Total RNA underwent linear amplification in a two-step procedure and was labeled and hybridized to each array according to the manufacturer's instructions using the small sample protocol. Human GeneChip U133A arrays (Affymetrix) were then washed using the Affymetrix Fluidics Station 400 and scanned using a HP GeneArray scanner. The array image was acquired using the Affymetrix GeneChip Microarray Suite 5.0. Software. The samples were normalized using the MAS5 method and scaled to a target value of 100.
Quality control
We used Bioconductor packages (simpleaffy [2] and arrayQualityMetrics [3] ) to assess the quality of the array experiment. As shown in 
Contents lists available at ScienceDirect
Genomics Data j o u r n a l h o m e p a g e : h t t p : / / w w w . j o u r n a l s . e l s e v i e r . c o m / g e n o m i c s -d a t a / Fig. 1 , samples are affected by slight degradation likely due to the elaborate cell selection and material isolation procedures followed by two amplification steps. In addition, a slight batch effect can be observed. Nevertheless, good sample comparability is given, because the degree of degradation is almost identical across all samples and the batch effect, which manifests as an overall higher signal intensity in one group, is readily eliminated during the normalization process.
Basic microarray analysis
The expression data of primary ALL at diagnosis (I1s, I2s, I3s, and I4; s, sorted cellular material) were independently filtered based on defined cutoff criteria such as present call, signal intensity (SI) ≥ 20, increase (I) or decrease call (D), change P value ≤ 0.003 for I/≥0.997 for D and signal log ratio (SLR) ≥ 0.5849 for I/≤−0.415 for D (equivalent to 1.5× up-or down-regulation), which arose from the comparison with the corresponding remission material (E1s, E2s, E3s, and E4s) as control. In all comparisons initial scaling was set to a target signal of 100. All genes meeting these cutoff criteria were considered to be differentially expressed, as depicted in the heatmap.
Quantitative real-time PCR
Ahead of high-resolution genomic profiling ZNF423 expression was evaluated by quantitative real time PCR (qPCR) in 200 primary Bprecursor ALL samples. For this purpose RNA isolation was performed after TRIZOL lysis (Invitrogen) according to manufacturer's instructions. TRIZOL-isolated RNA was reverse transcribed to cDNA by M-MLV reverse transcriptase for 1 h at 37°C using random primers (Promega). qPCR was carried out with SYBR Green I (Roche) according to manufacturer's instructions using following primers: ZNF423 (NM_ 015069.2) fw: 5′-gca gac ctg acg gac cac-3′ and rev-5′-agg cca ccc agg aga gtt-3′; and beta-2-microglobulin (B2M, NM_004048) fw: 5′-ttc tgg cct gga ggc tatc-3′ and rev: 5′-tca gga aat ttg act ttc cat tc-3′. Relative mRNA levels were depicted after normalization to B2M (2 −ΔCt *1000) as a reference gene. For genomic profiling ALL samples from 20 patients that showed a significantly higher ZNF423 expression than hematopoietic/lymphopoietic progenitors at various stages of development, were selected.
High resolution genomic profiling
Genomic DNA was isolated from 20 initial ALL samples and intraindividually matched mononuclear cells (MNC) from remission bone marrow using the QIAGEN DNA Blood Mini Kit following the manufacturer's instructions. Sample preparation, hybridization and staining were performed according to the manufacturer's standard protocol for Affymetrix Genome-Wide Human SNP 6.0 microarrays. Arrays were scanned on an Affymetrix 3000 7G GeneChip scanner using the Affymetrix Command Console Software. Processing of the raw signals and raw copy-number calculation were performed using the CRMA (version 2) procedure (Aroma, Affymetrix Package Version 2.0.0) for R statistical platform (version 2.12.1) according to the Aroma Affymetrix vignette for paired total copy-number analysis. CBS algorithm (DNA copy package version 1.24.0) was then applied to perform segmentation. Quality was accessed using the Contrast QC metric recommended by Affymetrix and displayed in Table 2 .
Discussion
In this report we provide an extended description of materials and methods for two datasets deposited in the GEO database containing gene expression and high-resolution genomic profiling data. The corresponding biologic material was isolated from fluorescence activated sorted primary leukemic cells (except one case) and normal lymphoblasts (gene expression data) as well as from 20 initial ALL and intraindividually matched MNC from remission bone marrow (genomic data). Based on these data we identified a potentially causative role for ZNF423 in ALL by its interference with B-cell differentiation and modulation of Smad1-Smad4 dependent transcription [1] . We encourage the use of our deposited datasets for further investigation into mechanistic underpinnings of ALL. We will provide further information if needed. 
